The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(1-Acryloylpiperidin-3-yl)-5-(5-isopropoxy-2-methylphenyl)-4-oxo-4,5-dihydro-3H-1-thia-3,5,8-triazaacenaphthylene-2-carboxamide ID: ALA4877368
PubChem CID: 129220195
Max Phase: Preclinical
Molecular Formula: C27H29N5O4S
Molecular Weight: 519.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N1CCC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2cc(OC(C)C)ccc2C)C1
Standard InChI: InChI=1S/C27H29N5O4S/c1-5-21(33)31-12-6-7-17(14-31)29-25(34)24-23-22-19(10-11-28-26(22)37-24)32(27(35)30-23)20-13-18(36-15(2)3)9-8-16(20)4/h5,8-11,13,15,17H,1,6-7,12,14H2,2-4H3,(H,29,34)(H,30,35)/t17-/m1/s1
Standard InChI Key: RZQRFSYZDSHHJL-QGZVFWFLSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
1.5487 -18.0224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5476 -18.8499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2624 -19.2627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9790 -18.8494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9760 -18.0187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2606 -17.6096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6918 -19.2600 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1192 -19.2612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4036 -18.8452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6943 -20.0859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9861 -20.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9847 -21.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6972 -21.7213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4040 -21.3094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1209 -20.0884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4060 -20.4999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3969 -21.3944 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.7333 -20.6412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5406 -20.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0918 -21.0844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7964 -19.6863 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6037 -19.5157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1507 -20.1326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9547 -19.9647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2148 -19.1813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6644 -18.5655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8538 -18.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4031 -18.0201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9229 -17.7820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7309 -17.6142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3738 -17.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6324 -16.3828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2622 -20.0878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2582 -16.7845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9715 -16.3699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9690 -15.5448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6872 -16.7803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 10 1 0
7 9 1 0
15 8 1 0
8 9 1 0
4 7 1 0
16 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
16 14 1 0
15 16 1 0
17 18 1 0
18 15 2 0
17 14 1 0
18 19 1 0
19 20 2 0
19 21 1 0
22 21 1 1
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
9 28 2 0
26 29 1 0
29 30 2 0
29 31 1 0
31 32 2 0
3 33 1 0
6 34 1 0
34 35 1 0
35 36 1 0
35 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 519.63Molecular Weight (Monoisotopic): 519.1940AlogP: 4.98#Rotatable Bonds: 6Polar Surface Area: 103.87Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.22CX Basic pKa: 0.38CX LogP: 4.15CX LogD: 4.15Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.45Np Likeness Score: -1.37
References 1. Tichenor MS, Wiener JJM, Rao NL, Pooley Deckhut C, Barbay JK, Kreutter KD, Bacani GM, Wei J, Chang L, Murrey HE, Wang W, Ahn K, Huber M, Rex E, Coe KJ, Wu J, Seierstad M, Bembenek SD, Leonard KA, Lebsack AD, Venable JD, Edwards JP.. (2021) Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory Activity., 12 (5.0): [PMID:34055226 ] [10.1021/acsmedchemlett.1c00044 ]